Schwabe Stefan K.F.
Insider CIK 1557657 · SUPN Executive Vice President R&D
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SUPN SUPERNUS PHARMACEUTICALS, | M Exercise deriv | 2020-12-21 | 2020-12-22 | 46,347 | — | $0 | 0 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | M Exercise | 2020-12-21 | 2020-12-22 | 46,347 | $12.98 | $601.6K | 49,119 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | S Sale | 2020-12-21 | 2020-12-22 | 46,347 | $22.10 | $1.02M | 2,772 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | M Exercise deriv | 2020-12-14 | 2020-12-15 | 3,653 | — | $0 | 46,347 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | M Exercise deriv | 2020-12-14 | 2020-12-15 | 50,000 | — | $0 | 0 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | M Exercise | 2020-12-14 | 2020-12-15 | 3,653 | $12.98 | $47.4K | 56,425 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | M Exercise | 2020-12-14 | 2020-12-15 | 50,000 | $9.13 | $456.5K | 52,772 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | S Sale | 2020-12-14 | 2020-12-15 | 50,000 | $21.86 | $1.09M | 6,425 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | S Sale | 2020-12-14 | 2020-12-15 | 3,653 | $22.00 | $80.4K | 2,772 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award deriv | 2020-02-21 | 2020-02-25 | 50,000 | — | $0 | 50,000 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | A Award deriv | 2019-02-22 | 2019-02-26 | 40,000 | — | $0 | 40,000 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | M Exercise deriv | 2018-06-18 | 2018-06-19 | 20,000 | — | $0 | 0 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | M Exercise deriv | 2018-06-18 | 2018-06-19 | 40,000 | — | $0 | 0 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | M Exercise | 2018-06-18 | 2018-06-19 | 20,000 | $7.90 | $158.0K | 21,967 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | M Exercise | 2018-06-18 | 2018-06-19 | 40,000 | $9.24 | $369.6K | 61,967 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | S Sale | 2018-06-18 | 2018-06-19 | 60,000 | $54.39 | $3.26M | 1,967 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | A Award deriv | 2018-02-14 | 2018-02-16 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | M Exercise deriv | 2017-09-07 | 2017-09-11 | 95,000 | — | $0 | 0 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | S Sale | 2017-09-07 | 2017-09-11 | 95,000 | $46.59 | $4.43M | 1,855 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | M Exercise | 2017-09-07 | 2017-09-11 | 95,000 | $12.92 | $1.23M | 96,855 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | A Award deriv | 2017-02-24 | 2017-02-27 | 50,000 | — | $0 | 50,000 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | A Award deriv | 2016-03-01 | 2016-03-03 | 50,000 | — | $0 | 50,000 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | S Sale | 2015-07-28 | 2015-07-29 | 650 | $21.21 | $13.8K | 1,700 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | S Sale | 2015-07-28 | 2015-07-29 | 1,700 | $21.20 | $36.0K | 0 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | S Sale | 2015-07-13 | 2015-07-14 | 1,950 | $19.23 | $37.5K | 844 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | S Sale | 2015-07-13 | 2015-07-29 | 1,950 | $19.23 | $37.5K | 2,350 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | S Sale | 2015-06-12 | 2015-06-15 | 2,051 | $18.27 | $37.5K | 2,794 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | S Sale | 2015-06-11 | 2015-06-12 | 1,345 | $16.32 | $22.0K | 7,131 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | S Sale | 2015-06-11 | 2015-06-12 | 2,286 | $16.44 | $37.6K | 4,845 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | A Award deriv | 2015-03-03 | 2015-03-05 | 50,000 | — | $0 | 50,000 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | A Award deriv | 2014-01-21 | 2014-01-23 | 40,000 | — | $0 | 40,000 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | A Award deriv | 2013-02-05 | 2013-02-07 | 20,000 | — | $0 | 20,000 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | A Award deriv | 2012-08-09 | 2012-09-07 | 95,000 | — | $0 | 95,000 | SEC↗ |